JPH08508292A - (S)−α−フェニル−2−ピリジンエタンアミン(S)−マレートおよび医薬としてのその使用 - Google Patents
(S)−α−フェニル−2−ピリジンエタンアミン(S)−マレートおよび医薬としてのその使用Info
- Publication number
- JPH08508292A JPH08508292A JP6521814A JP52181494A JPH08508292A JP H08508292 A JPH08508292 A JP H08508292A JP 6521814 A JP6521814 A JP 6521814A JP 52181494 A JP52181494 A JP 52181494A JP H08508292 A JPH08508292 A JP H08508292A
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- malate
- pyridinethanamine
- enantiomeric purity
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.エナンチオマー純度が90%より高い(S)−α−フェニル−2−ピリジンエ タンアミン(S)−マレート。 2.エナンチオマー純度が99%より高い(S)−α−フェニル−2−ピリジンエ タンアミン(S)−マレート。 3.(S)−α−フェニル−2−ピリジンエタンアミン(S)−マレート。 4.医薬的に許容される補助剤、希釈剤または担体との混合物中に請求項1〜3 の何れかに記載の(S)−α−フェニル−2−ピリジンエタンアミン(S)−マ レートを含有する医薬処方物。 5.薬剤として使用するための請求項1〜3の何れか一項に記載の(S)−α− フェニル−2−ピリジンエタンアミン(S)−マレート。 6.神経変性疾患の治療のための医薬の製造における活性成分としての請求項1 〜3の何れか一項に記載の(S)−α−フェニル−2−ピリジンエタンアミン( S)−マレートの使用。 7.患者に請求項1〜3の何れか一項に記載の(S)−α−フェニル−2−ピリ ジンエタンアミン(S)−マレートの治療有効量を投与することを包含する神経 変性疾患の治療方法。 8.投与する化合物の用量が所望の化合物の血漿中濃度と正比例する請求項7記 載の治療方法。 9.下記段階: (a)α−フェニル−2−ピリジンエタンアミンまたはその塩およびエナンチ オマー度が90%より高い(S)−リンゴ酸の混合物の溶液からの沈殿;または、 (b)エナンチオマー純度が90%より高い(S)−α−フェニル−2−ピリジ ンエタンアミンまたはその塩、および、エナンチオマー純度が90%より高い(S )−リンゴ酸の混合物の溶液からの沈殿 を包含する請求項1〜3の何れか一項に記載の(S)−α−フェニル−2−ピリ ジンエタンアミン(S)−マレートの製造方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB1993/000689 WO1993020052A1 (en) | 1992-04-03 | 1993-04-01 | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
GB9320273.7 | 1993-10-01 | ||
GB939320273A GB9320273D0 (en) | 1993-04-01 | 1993-10-01 | Compound useful in therapy |
GB93/00689 | 1993-10-01 | ||
PCT/GB1994/000651 WO1994022831A1 (en) | 1993-04-01 | 1994-03-29 | (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08508292A true JPH08508292A (ja) | 1996-09-03 |
JP3023987B2 JP3023987B2 (ja) | 2000-03-21 |
Family
ID=26302299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6521814A Expired - Lifetime JP3023987B2 (ja) | 1993-04-01 | 1994-03-29 | (S)−α−フェニル−2−ピリジンエタンアミン(S)−マレートおよび医薬としてのその使用 |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0691957B1 (ja) |
JP (1) | JP3023987B2 (ja) |
CN (1) | CN1047168C (ja) |
AT (1) | ATE156813T1 (ja) |
AU (1) | AU682348B2 (ja) |
CA (1) | CA2159478C (ja) |
DE (1) | DE69404974T2 (ja) |
DK (1) | DK0691957T3 (ja) |
DZ (1) | DZ1765A1 (ja) |
ES (1) | ES2105672T3 (ja) |
FI (1) | FI109018B (ja) |
GB (1) | GB9320273D0 (ja) |
GR (1) | GR3025081T3 (ja) |
IL (1) | IL109108A (ja) |
MA (1) | MA23154A1 (ja) |
NO (1) | NO304647B1 (ja) |
PH (1) | PH30950A (ja) |
SG (1) | SG48204A1 (ja) |
WO (1) | WO1994022831A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003524625A (ja) * | 1999-04-15 | 2003-08-19 | アストラゼネカ・アクチエボラーグ | 新規プロセス |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE68925933T2 (de) * | 1988-08-12 | 1996-08-14 | Fisons Corp | Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung |
ZA942140B (en) * | 1993-04-01 | 1994-10-03 | Fisons Corp | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
SE9901338D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
DE10301650A1 (de) * | 2003-01-17 | 2004-07-29 | Johannes-Gutenberg-Universität Mainz | Medizinisch nützliche 1-Phenyl-2-aminomethylnaphthaline, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung |
UA106056C2 (uk) | 2008-12-24 | 2014-07-25 | Астразенека Аб | Сполуки 2-метил-1-феніл-2-(піридин-2-іл)пропан-1-аміну та їх застосування для лікування депресії |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3422191A (en) * | 1965-01-21 | 1969-01-14 | Synergistics Inc | Compositions and methods for tranquilization employing salts of n-morpholine ethanol |
DE68925933T2 (de) * | 1988-08-12 | 1996-08-14 | Fisons Corp | Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung |
JP2514855B2 (ja) * | 1990-08-08 | 1996-07-10 | キッセイ薬品工業株式会社 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
KR100259567B1 (ko) * | 1992-04-03 | 2000-07-01 | 클래스 빌헬름슨 | 신경변성 질환 치료용 1-페닐-2-(2-피리디닐)에틸아민 에난티오머 |
-
1993
- 1993-10-01 GB GB939320273A patent/GB9320273D0/en active Pending
-
1994
- 1994-03-24 IL IL10910894A patent/IL109108A/en not_active IP Right Cessation
- 1994-03-29 CA CA002159478A patent/CA2159478C/en not_active Expired - Lifetime
- 1994-03-29 JP JP6521814A patent/JP3023987B2/ja not_active Expired - Lifetime
- 1994-03-29 AU AU63802/94A patent/AU682348B2/en not_active Expired
- 1994-03-29 DE DE69404974T patent/DE69404974T2/de not_active Expired - Lifetime
- 1994-03-29 PH PH48016A patent/PH30950A/en unknown
- 1994-03-29 AT AT94911232T patent/ATE156813T1/de active
- 1994-03-29 SG SG1996007883A patent/SG48204A1/en unknown
- 1994-03-29 DK DK94911232.0T patent/DK0691957T3/da active
- 1994-03-29 EP EP94911232A patent/EP0691957B1/en not_active Expired - Lifetime
- 1994-03-29 WO PCT/GB1994/000651 patent/WO1994022831A1/en active IP Right Grant
- 1994-03-29 ES ES94911232T patent/ES2105672T3/es not_active Expired - Lifetime
- 1994-03-30 DZ DZ940029A patent/DZ1765A1/fr active
- 1994-04-01 CN CN94103739A patent/CN1047168C/zh not_active Expired - Lifetime
- 1994-04-01 MA MA23459A patent/MA23154A1/fr unknown
-
1995
- 1995-09-28 NO NO951546A patent/NO304647B1/no not_active IP Right Cessation
- 1995-09-29 FI FI954645A patent/FI109018B/fi not_active IP Right Cessation
-
1997
- 1997-10-17 GR GR970402722T patent/GR3025081T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003524625A (ja) * | 1999-04-15 | 2003-08-19 | アストラゼネカ・アクチエボラーグ | 新規プロセス |
JP4676064B2 (ja) * | 1999-04-15 | 2011-04-27 | アストラゼネカ・アクチエボラーグ | 新規プロセス |
Also Published As
Publication number | Publication date |
---|---|
DK0691957T3 (da) | 1997-10-27 |
DE69404974T2 (de) | 1997-12-18 |
FI109018B (fi) | 2002-05-15 |
DE69404974D1 (de) | 1997-09-18 |
EP0691957B1 (en) | 1997-08-13 |
AU6380294A (en) | 1994-10-24 |
IL109108A0 (en) | 1994-06-24 |
MA23154A1 (fr) | 1994-12-31 |
GB9320273D0 (en) | 1993-11-17 |
ATE156813T1 (de) | 1997-08-15 |
CA2159478A1 (en) | 1994-10-13 |
PH30950A (en) | 1997-12-23 |
FI954645A0 (fi) | 1995-09-29 |
CN1098095A (zh) | 1995-02-01 |
JP3023987B2 (ja) | 2000-03-21 |
IL109108A (en) | 1999-01-26 |
CN1047168C (zh) | 1999-12-08 |
CA2159478C (en) | 2005-01-25 |
NO304647B1 (no) | 1999-01-25 |
WO1994022831A1 (en) | 1994-10-13 |
SG48204A1 (en) | 1998-04-17 |
GR3025081T3 (en) | 1998-01-30 |
AU682348B2 (en) | 1997-10-02 |
ES2105672T3 (es) | 1997-10-16 |
NO953846L (no) | 1995-11-21 |
NO953846D0 (no) | 1995-09-28 |
EP0691957A1 (en) | 1996-01-17 |
DZ1765A1 (fr) | 2002-02-17 |
FI954645A (fi) | 1995-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0633879B1 (en) | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders | |
JPH08508292A (ja) | (S)−α−フェニル−2−ピリジンエタンアミン(S)−マレートおよび医薬としてのその使用 | |
KR102269493B1 (ko) | (r)-디미라세탐 (1) 및 (s)-디미라세탐 (2)을 비-라세미 비로 포함하는 상승작용적 조성물 | |
US5455259A (en) | Compounds for the treatment of neurodegenerative disorders | |
JP3023988B2 (ja) | (S)−α−フェニル−2−ピリジンエタンアミンベンゾエートおよび医薬としてのその使用 | |
WO2012033435A1 (ru) | Способ, соединение, фармацевтическая композиция и лекарственное средство для восстановления утраченной памяти в норме и патологии | |
WO2012030258A1 (ru) | Гетероциклические низкомолекулярные sapp-миметики, фармацевтическая композиция, способы получения и применения | |
TW390875B (en) | (S) -<alpha>-phenyl-2-pyridineethanamine (S)-malate useful in therary, its perparing process and pharmaceutical composition comprising the same | |
DE10306202A1 (de) | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen | |
DE10045831A1 (de) | Thio-Aminosäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080121 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120121 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130121 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130121 Year of fee payment: 13 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |